The company will be divided into two divisions: Nanisx Pain for interventional pain management and Nanisx Ortho-Neuro, according to a Sept. 6 news release. Dr. Chin, CEO and founder of KICVentures Group, merged the investment firm’s holdings in three portfolio companies, NanoFUSE Biologics, InSpan and Sacrix, to create Nanisx.
Nanisx plans to announce a CEO in the near future, and the process to initiate an IPO was started.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.